Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Minimalist illustration of a protein structure

Oct 21, 2026

NVIDIA releases a tool to help scientists design new proteins, with possible uses in medicine.

NVIDIA has unveiled a new tool, RFD4-Proteina, aimed at revolutionizing protein design, which could significantly impact drug discovery and cancer treatment.The collaboration between NVIDIA and the UW Medicine Institute for Protein Design has led to the introduction of RFD4-Proteina, an open model designed to enhance the process of creating new proteins. This model allows scientists to generate targeted protein designs by utilizing molecular inputs and scoring objectives, thereby streamlining th
A miniprotein in a test tube on a lab bench in a dimly lit laboratory.

Oct 21, 2026

Astellas links up with AI Proteins in $400M computational d rugdiscovery deal

Japan's Astellas Pharma has entered a significant partnership with AI Proteins, a Boston-based computational discovery firm, in a deal potentially valued at $400 million aimed at revolutionizing drug discovery.AI Proteins specializes in creating miniproteins using a computational design platform that allows for the development of novel molecules tailored for specific therapeutic functions. This approach contrasts with traditional methods that rely on naturally occurring biologics. According to A
Press release cover image

Oct 21, 2026

Press release

St George's and Epsom hospitals turn to MazeMap to improve the patient experience

NHS hospital group gesh introduces digital wayfinding to help patients navigate changing hospital sitesTRONDHEIM, Norway, Oct. 21, 2026 /PRNewswire/ -- St George's and Epsom hospitals have introduced MazeMap digital wayfinding to help patients and visitors find their way to care. The hospitals are part of St George's, Epsom and St Helier University Hospitals and Health Group (gesh), which secured New Hospital Programme innovation funding for the project.Building work and service relocations can
A minimalist illustration of a pill and a virus, symbolizing antiviral drug discovery.

Oct 21, 2026

Inside the ‘Public Library of Blueprints’: How the ASAP Discovery Consortium Turned Open Science Into an Antiviral Pipeline

The ASAP Discovery Consortium has redefined drug discovery through an innovative open-science model, earning recognition for its efforts to create a collaborative antiviral pipeline.In a recent presentation at the Bio-IT World Conference & Expo, Nick Lynch, a leader in the project, detailed the consortium's journey of establishing a global network of 20 institutes focused on antiviral development. This initiative, born from the lessons of the COVID-19 pandemic, aims to produce clinic-ready antiv
Press release cover image

Oct 21, 2026

Press release

Median Technologies Strengthens Its Engagement with the International Lung Cancer Screening Community at the 50th I-ELCAP Conference in New York

Median Technologies and its U.S. subsidiary eyonis Inc. will present eyonis® LCS at this landmark meeting of the international lung cancer screening communityI-ELCAP has played a pioneering role in advancing the scientific evidence and international adoption of low-dose CT lung cancer screeningThe conference will bring together many of the world’s leading experts in lung cancer screening, including I-ELCAP pioneersFollowing FDA clearance and CE marking, Median Technologies and eyonis Inc. are ad
Press release cover image

Oct 21, 2026

Press release

bitBiome Achieves Milestones in Joint Development Project with Ajinomoto Co., Inc.

TOKYO, Oct. 20, 2026 /PRNewswire/ -- bitBiome, Inc. (Headquarters: Tokyo; Representative Director and CEO: Yuji Suzuki) is pleased to announce the achievement of target milestones stipulated in the joint development contract with Ajinomoto Co., Inc. (Headquarters: Chuo-ku, Tokyo; President & CEO: Shigeo Nakamura), which was previously announced on December 21, 2023. In recognition of this milestone, bitBiome has received the associated success fee.In this project, bitBiome utilized its propr
Press release cover image

Oct 21, 2026

Press release

Insilico Medicine and Servier Achieve First Milestone in AI-Driven R&D Collaboration, Triggering An undisclosed Milestone Payment

Two programs under the multi-year R&D collaboration have initiated and completed target nomination since its early 2026 announcement.Insilico reached the first R&D milestone using its proprietary Pharma.AI platform, triggering an undisclosed milestone payment from Servier.The multi-targets oncology collaboration of both parties, announced in early 2026, carries a total value of up to $888 million with $32 million in upfront and near-term R&D payments.CAMBRIDGE, Mass., Oct. 20, 2026 /
Press release cover image

Oct 21, 2026

Press release

Metabolon Announces New Bioinformatics Application to Translate Metabolomic Biomarkers into Actionable Multiomic Hypotheses

New bioinformatics application combines curated metabolite-protein knowledge, advanced network algorithms, interactive exploration, and optional AI interpretation to generate clearer mechanistic hypothesesMORRISVILLE, N.C., Oct. 20, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in metabolomics solutions advancing life sciences research, diagnostics, therapeutics, and precision medicine, today announced Splash & Ripple, a new bioinformatics application within the company's Integrate
Press release cover image

Oct 21, 2026

Press release

Optum and Syneos Health Partner to Advance an Adaptive Clinical Development Model

Partnership Will Transform How Clinical Development is Designed and Executed MORRISVILLE, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Syneos Health® today announced a partnership with Optum to build a more adaptive and connected model for clinical development, helping biopharmaceutical companies deliver promising therapies to patients sooner. The collaboration will bring together Optum’s healthcare industry knowledge, specialized expertise and AI resources with Syneos Health’s clinical development
Liquid handling platform in a laboratory setting with RNA-seq kits

Oct 20, 2026

Takara Bio USA, SPT Labtech Team Up to Automate NGS Library Prep Workflows

Takara Bio USA and SPT Labtech have partnered to enhance automation in next-generation sequencing (NGS) library preparation workflows.The collaboration aims to integrate Takara Bio’s SMART-seq® RNA-seq library preparation chemistries with SPT Labtech’s firefly liquid handling platform. Initially, the focus will be on optimizing specific RNA-seq workflows, with plans to expand to a wider range of RNA-seq, DNA-seq, and immune profiling kits. This partnership primarily targets NGS core labs that ha
Press release cover image

Oct 20, 2026

Press release

Sophont Launches Holon-S1 to Reveal Tumor Biology from Routine Pathology Slides

SACRAMENTO, Calif., Oct. 20, 2026 /PRNewswire/ -- Sophont, a frontier medical AI startup, announces Holon-S1, a pan-cancer AI model that predicts spatial gene and biological pathway activity from routine hematoxylin and eosin (H&E) pathology slides. By using widely available pathology slides, Holon-S1 aims to broaden access to insights that typically require costly and time-consuming molecular testing, supporting biomarker discovery and personalized treatment research.Continue Reading
A minimalist illustration of a telehealth device and a cancer cell in flat design.

Oct 20, 2026

Telemedicine helps reduce admissions, cut costs for cancer patients, study finds

A recent study involving over 5,400 cancer patients has revealed that Daymark Health's supportive oncology program, which integrates telemedicine and in-home care, significantly reduces hospital admissions and healthcare costs.The study, conducted across 20 oncology practices, found that patients enrolled in this program experienced a 10.4% decrease in hospital admissions and an 8.1% reduction in overall healthcare spending. Launched in collaboration with Blue Cross & Blue Shield of Rhode Island